<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib13">
 <label>13</label>
 <element-citation publication-type="journal" id="sref13">
  <person-group person-group-type="author">
   <name>
    <surname>Jacobs</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Grum-Tokars</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Zhou</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Turlington</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Saldanha</surname>
    <given-names>S.A.</given-names>
   </name>
   <name>
    <surname>Chase</surname>
    <given-names>P.</given-names>
   </name>
  </person-group>
  <article-title>Discovery, synthesis, and structure-based optimization of a series of N-(tert-butyl)-2-(N-arylamido)-2-(pyridin-3-yl) acetamides (ML188) as potent noncovalent small molecule inhibitors of the severe acute respiratory syndrome coronavirus (SARS-CoV) 3CL protease.</article-title>
  <source>J. Med. Chem.</source>
  <volume>56</volume>
  <year>2013</year>
  <fpage>534</fpage>
  <lpage>546</lpage>
  <pub-id pub-id-type="pmid">23231439</pub-id>
 </element-citation>
</ref>
